Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 16, 2004. The report details a share repurchase transaction executed under shareholder authority granted at the Annual General Meeting on May 17, 2004, and discloses changes in directors' interests related to the GlaxoSmithKline Employee Trust.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The only financial data presented relates to capital structure and share transactions:
- Shares Repurchased: 1,000,000 Ordinary Shares.
- Repurchase Price: 1,167.66 pence per Share.
- Transaction Date: December 15, 2004.
- Treasury Shares Held: 66,448,000 (post-transaction).
- Shares in Issue: 5,870,826,281 (excluding treasury shares).
Material Changes
The primary material change is the reduction of outstanding shares through the open market purchase of 1,000,000 shares, which are now held in treasury. Additionally, the GlaxoSmithKline Employee Trust transferred 3,480 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991 on December 15, 2004.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities. No specific risks or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the total cost of the 1,000,000 share repurchase against the stated price of 1,167.66 pence.
- Confirm the updated total share count (5,870,826,281 in issue) against subsequent filings.
- Review the impact of the 66,448,000 treasury shares on earnings per share calculations in future reports.
- Check for any further disclosures regarding the SmithKline Beecham Employee Share Option Plan 1991.